Home LiteratureArticle Details
PMID: 9119745 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Direct intratumoral gene transfer of the herpes simplex virus thymidine kinase gene with DNA-liposome complexes: growth inhibition of tumors and lack of localization in normal tissues.

Japanese journal of cancer research : Gann ·Vol. 88 ·No. 2 ·1997-02-00 ·Pages 166-75

Takakuwa K, Fujita K, Kikuchi A, Sugaya S, Yahata T, Aida H, Kurabayashi T, Hasegawa I, Tanaka K

Abstract

To constitute the site-specific expression of the herpes simplex virus thymidine-kinase (HSV-TK) gene in tumor cells, we have assessed the promoter function of the simian virus 40 (SV40) promoter and the 5'flanking region of c-erbB-2 gene using a luciferase-expressing reporter plasmid. After the transfection of the luciferase plasmid directed by the promoter region of c-erbB-2 gene, a large amount of luciferase activity was observed in c-erbB-2-expressing cells (Colo201, MCF-7, and HEC1-A), while none was detected in cells with no expression of c-erbB-2 protein (HRA and KF cells). On the other hand, a high level of luciferase activity was detected in all tumor cell lines tested, when the transfection was performed with SV40 promoter. The repeated transfection of the liposome-conjugated HSV-TK gene regulated by the SV40 promoter or by the promoter region of c-erbB-2 gene with cultivation in 100 micrograms/ml of aciclovir for 5 days in vitro resulted in growth inhibition for all four cell lines examined or for only c-erbB-2-expressing cells in the presence of SV40 promoter or c-erbB-2 promoter, respectively. Finally, direct injection of the DNA-liposome complex into established tumors in the presence of 50 mg/kg of aciclovir led to significant tumor volume reduction in all three tumors tested when SV40 promoter was employed. However, this anti-tumor effect was noted only in c-erbB-2-positive cells (Colo201 cells) upon intratumoral injection of HSV-TK gene regulated by c-erbB-2 promoter. In the case of intratumoral gene transfer, foreign DNA was detected in only one of seven mice by polymerase chain reaction (PCR) analysis performed 7 days following injection. When PCR analysis was carried out at 14 or 21 days following injection, no DNA signal was found at all. However, DNA was detected in several normal tissues at all three times tested in the case of intravenous injection. No abnormalities were seen in histologic examinations of normal tissues or in serum biochemical parameters following DNA liposome delivery. These results suggest that the direct gene transfer of HSV-TK gene regulated by tumor-specific transcriptional units may be one of the most clinically promising of the selective genetic strategies against cancer.

MeSH Terms
Acyclovir/pharmacology Adenocarcinoma/therapy Animals Antiviral Agents/pharmacology Colonic Neoplasms/therapy Female Flow Cytometry Gene Transfer Techniques Genes, Reporter Genes, erbB-2/genetics Genetic Vectors/genetics Herpesvirus 1, Human/drug effects,enzymology Humans Liposomes Luciferases/genetics,metabolism Mice Mice, Nude Promoter Regions, Genetic/genetics Receptor, ErbB-2/metabolism Thymidine Kinase/genetics,pharmacokinetics Tissue Distribution Transcription, Genetic Transplantation, Heterologous Tumor Cells, Cultured Viral Proteins/genetics beta-Galactosidase/genetics,metabolism
Chemicals
Antiviral Agents Liposomes Viral Proteins Luciferases Thymidine Kinase Receptor, ErbB-2 beta-Galactosidase Acyclovir
Authors & Affiliations
9 authors, click to expand affiliations / ORCID
Takakuwa K
Department of Obstetrics and Gynecology, Niigata University School of Medicine.
Fujita K
Kikuchi A
Sugaya S
Yahata T
Aida H
Kurabayashi T
Hasegawa I
Tanaka K
References (35)
35 references, click to expand
  1. Gene therapy for cancer using tumour-specific prodrug activation.
    Gene Ther. 1994 May;1(3):170-5 PMID: 7584078
  2. In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats.
    Cancer Res. 1993 Jan 1;53(1):83-8 PMID: 8380127
  3. A novel cationic liposome reagent for efficient transfection of mammalian cells.
    Biochem Biophys Res Commun. 1991 Aug 30;179(1):280-5 PMID: 1883357
  4. Gene therapy for cancer.
    Lancet. 1992 Mar 21;339(8795):715-21 PMID: 1347590
  5. The "bystander effect": tumor regression when a fraction of the tumor mass is genetically modified.
    Cancer Res. 1993 Nov 1;53(21):5274-83 PMID: 8221662
  6. Metabolism of 5-fluorocytosine to 5-fluorouracil in human colorectal tumor cells transduced with the cytosine deaminase gene: significant antitumor effects when only a small percentage of tumor cells express cytosine deaminase.
    Proc Natl Acad Sci U S A. 1994 Aug 16;91(17):8302-6 PMID: 8058798
  7. Interactions of mammalian cells with lipid dispersions containing novel metabolizable cationic amphiphiles.
    Biochim Biophys Acta. 1990 Mar 30;1023(1):124-32 PMID: 2317491
  8. Characterization of the promoter region of the human c-erbB-2 protooncogene.
    Proc Natl Acad Sci U S A. 1987 Jul;84(13):4374-8 PMID: 2885835
  9. Combination gene therapy for liver metastasis of colon carcinoma in vivo.
    Proc Natl Acad Sci U S A. 1995 Mar 28;92(7):2577-81 PMID: 7708688
  10. Retroviral-mediated gene therapy for the treatment of hepatocellular carcinoma: an innovative approach for cancer therapy.
    Proc Natl Acad Sci U S A. 1991 Sep 15;88(18):8039-43 PMID: 1654555
  11. Lipophilic polylysines mediate efficient DNA transfection in mammalian cells.
    Biochim Biophys Acta. 1991 May 31;1065(1):8-14 PMID: 2043655
  12. Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans.
    Proc Natl Acad Sci U S A. 1993 Dec 1;90(23):11307-11 PMID: 8248244
  13. Gene transfer in vivo with DNA-liposome complexes: safety and acute toxicity in mice.
    Hum Gene Ther. 1992 Jun;3(3):267-75 PMID: 1643147
  14. Cell lines from human colon carcinoma with unusual cell products, double minutes, and homogeneously staining regions.
    Cancer Res. 1979 Dec;39(12):4914-24 PMID: 498117
  15. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors.
    Science. 1992 Jun 12;256(5063):1550-2 PMID: 1317968
  16. Expression of ERBB2 in human gastric carcinomas: relationship between p185ERBB2 expression and the gene amplification.
    Cancer Res. 1990 Dec 15;50(24):8002-9 PMID: 1979253
  17. Safety and toxicity of catheter gene delivery to the pulmonary vasculature in a patient with metastatic melanoma.
    Hum Gene Ther. 1994 Sep;5(9):1089-94 PMID: 7833368
  18. Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor.
    Nature. 1986 Jan 16-22;319(6050):230-4 PMID: 3003577
  19. Transactivation of the TPA-responsive element by the oncogenic C-erbB-2 protein is partly mediated by protein kinase C.
    Biochem Biophys Res Commun. 1991 Jul 31;178(2):724-32 PMID: 1677566
  20. Human gene therapy comes of age.
    Nature. 1992 Jun 11;357(6378):455-60 PMID: 1608446
  21. In vitro evidence that metabolic cooperation is responsible for the bystander effect observed with HSV tk retroviral gene therapy.
    Hum Gene Ther. 1993 Dec;4(6):725-31 PMID: 8186287
  22. Gene transfer in vivo with DNA-liposome complexes: lack of autoimmunity and gonadal localization.
    Hum Gene Ther. 1992 Dec;3(6):649-56 PMID: 1482705
  23. Interleukin 1 is processed and released during apoptosis.
    Proc Natl Acad Sci U S A. 1991 Oct 1;88(19):8485-9 PMID: 1924307
  24. Strategy for achieving selective killing of carcinomas.
    Gene Ther. 1994 Jan;1(1):46-50 PMID: 7584059
  25. Reversal of oncogenesis by the expression of a major histocompatibility complex class I gene.
    Science. 1985 Apr 5;228(4695):26-30 PMID: 3975631
  26. Inhibition of tumor growth by direct intratumoral gene transfer of herpes simplex virus thymidine kinase gene with DNA-liposome complexes.
    Hum Gene Ther. 1996 Jan 20;7(2):223-30 PMID: 8788173
  27. Effects of calmodulin antagonists on human ovarian cancer cell proliferation in vitro.
    Biochem Biophys Res Commun. 1984 Aug 30;123(1):385-92 PMID: 6541042
  28. Tumor cell bystander killing in colonic carcinoma utilizing the Escherichia coli DeoD gene to generate toxic purines.
    Gene Ther. 1994 Jul;1(4):233-8 PMID: 7584086
  29. Induction of growth factor-receptor and metalloproteinase genes by epidermal growth factor and/or transforming growth factor-alpha in human gastric carcinoma cell line MKN-28.
    Jpn J Cancer Res. 1990 Aug;81(8):793-8 PMID: 2168868
  30. Establishment of a cell line of human endometrial adenocarcinoma in vitro.
    Am J Obstet Gynecol. 1972 Dec 15;114(8):1012-9 PMID: 4673779
  31. In vitro and in vivo targeting of gene expression to melanoma cells.
    Cancer Res. 1993 Mar 1;53(5):962-7 PMID: 8439971
  32. Human breast carcinoma cells in continuous culture: a review.
    Cancer Res. 1978 Nov;38(11 Pt 2):4327-39 PMID: 212193
  33. Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure.
    Proc Natl Acad Sci U S A. 1987 Nov;84(21):7413-7 PMID: 2823261
  34. Use of tissue-specific expression of the herpes simplex virus thymidine kinase gene to inhibit growth of established murine melanomas following direct intratumoral injection of DNA.
    Cancer Res. 1993 Sep 1;53(17):3860-4 PMID: 8395331
  35. Efficient gene transfer into mammalian primary endocrine cells with lipopolyamine-coated DNA.
    Proc Natl Acad Sci U S A. 1989 Sep;86(18):6982-6 PMID: 2780554
Article Info
Journal
Japanese journal of cancer research : Gann
Abbr.
Jpn J Cancer Res
ISSN
0910-5050
Published
1997-02-00
Pages
166-75
Language
English
Region
Japan
NLM ID
8509412
PMCID
PMC5921354
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]